WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006084016) ACID ADDITION SALTS OF Ac-PHSCN-NH2
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/084016    International Application No.:    PCT/US2006/003658
Publication Date: 10.08.2006 International Filing Date: 01.02.2006
IPC:
C07K 7/06 (2006.01), A61P 35/00 (2006.01)
Applicants: ATTENUON, LLC [US/US]; Suite 401, 11535 Sorrento Valley Road, San Diego, California 92121 (US) (For All Designated States Except US).
TERNANSKY, Robert, J. [US/US]; (US) (For US Only).
GLADSTONE, Patricia, L. [CA/US]; (US) (For US Only).
MAZAR, Andrew, P. [US/US]; (US) (For US Only).
ALLAN, Amy, L. [US/US]; (US) (For US Only)
Inventors: TERNANSKY, Robert, J.; (US).
GLADSTONE, Patricia, L.; (US).
MAZAR, Andrew, P.; (US).
ALLAN, Amy, L.; (US)
Agent: ANTLER, Adriane, M.; Jones Day, 222 East 41st Street, New York, New York 10017-6702 (US)
Priority Data:
60/649,308 01.02.2005 US
Title (EN) ACID ADDITION SALTS OF Ac-PHSCN-NH2
(FR) SELS D'ADDITION D'ACIDE DE AC-PHSCN-NH2
Abstract: front page image
(EN)Acid addition salts of Ac-PHSCN-NH2, methods of making acid addition salts of Ac-PHSCN-NH2, pharmaceutical compositions of acid addition salts of Ac-PHSCN-NH2, methods of using acid addition salts of Ac-PHSCN-NH2 and pharmaceutical compositions thereof to treat diseases associated with angiogenesis and aberrant vascularization and methods of preventing degradation of Ac-PHSCN-NH2 by salt formation are provided herein.
(FR)La présente invention se rapporte à des sels d'addition d'acide de Ac-PHSCN-NH2, à des procédés de fabrication desdits sels d'addition d'acide de Ac-PHSCN-NH2, à des compositions pharmaceutiques contenant lesdits sels d'addition d'acide de Ac-PHSCN-NH2, à des procédés d'utilisation desdits sels d'addition d'acide de Ac-PHSCN-NH2 et des compositions pharmaceutiques les contenant pour traiter des maladies associées à l'angiogenèse et à une vascularisation anormale, ainsi qu'à des procédés permettant de prévenir la dégradation de Ac-PHSCN-NH2 par la formation de sels.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)